GLUT1-mediated drug delivery technology for breaking through the blood-brain barrier.
All GLUT1-intervening molecules are patentable! Established as a conceptual patent in the country!
Our technology enables the transport of drugs into the brain across the blood-brain barrier through a mechanism known as transcytosis, by combining glucose ligand-modified polymer nanoparticles and blood glucose level control that activates GLUT1 circulation. Biodegradable carriers at the nanoscale can extend the circulation of drugs in the body and protect the drugs from the drug excretion mechanisms of the blood-brain barrier after they have been transported into the brain. 【Flow】 1: Glucose-modified polymer micelles interact with GLUT1 and are taken up by brain vascular endothelial cells. 2: The micelles move within the brain vascular endothelial cells. 3: The micelles detach from GLUT1 on the brain parenchyma side and transition into the brain parenchyma. 4: The micelles reach the neurons. 5: GLUT1 is reused. *For more details, please download the PDF or contact us.
Inquire About This Product
basic information
For more details, please download the PDF or contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please download the PDF or contact us.
catalog（1）
Download All Catalogs
Company information
Our company is a startup based on groundbreaking drug delivery technology for the brain. We are developing innovative technologies to efficiently deliver therapeutic drugs of various molecules to the brain. We aim to become a leading company in drug delivery to the central nervous system of the brain, enabling more effective delivery of treatments to patients suffering from central nervous system diseases. Please feel free to contact us if you have any inquiries.
![[Research Material] Global Market for Cancer Supportive Care Drugs](https://image.mono.ipros.com/public/product/image/aba/2001473036/IPROS74515055174871770939.jpeg?w=280&h=280)
